Mapping SARS-CoV-2 antigenic relationships and serological responses.
Samuel H WilksBarbara MühlemannXiaoying X ShenSina TüreliEric B LeGresleyAntonia NetzlMiguela A CanizaJesus N Chacaltana-HuarcayaVictor Max CormanXiaoju DaniellMichael B DattoFatimah S DawoodThomas N DennyChristian DrostenRon A M FouchierPatricia Jannet GarciaPeter J HalfmannAgatha JassemLara Maria JeworowskiTerry C JonesYoshihiro KawaokaFlorian KrammerCharlene McDanalRolando PajonViviana SimonMelissa S StockwellHaili TangHarm van BakelVic VeguillaRichard John WebbyDavid C MontefioriDerek J SmithPublished in: Science (New York, N.Y.) (2023)
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.